Article info
PDFSmall bowel and Nutrition
Case report
Rituximab to the rescue: novel therapy for chronic gastrointestinal bleeding due to angiodysplasia and acquired von Willebrand syndrome
- Correspondence to Dr James Hawken, Department of Hepatology University Hospitals Bristol NHS Foundation Trust Bristol UK ; jameshawken{at}doctors.org.uk
Citation
Rituximab to the rescue: novel therapy for chronic gastrointestinal bleeding due to angiodysplasia and acquired von Willebrand syndrome
Publication history
- Received October 2, 2018
- Revised November 19, 2018
- Accepted December 14, 2018
- First published January 9, 2019.
Online issue publication
April 09, 2020
Article Versions
- Previous version (6 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.